M PREMKUMAR
@docMPK
Followers
992
Following
1K
Statuses
732
Stranger in a Strange Land
Chandigarh, India
Joined May 2021
RT @Yujun__Wong: Anticoagulation did 🚫increase the risk of bleeding With/without anticoagulation during EVL, we found a similar risk of:…
0
15
0
RT @Yujun__Wong: High🟡 in non-🍺 cirrhosis reflect synthetic function High 🟡 in 🍺 cirrhosis may be influenced by AH phenotype with a higher…
0
1
0
Who benefits from early CRRT.. Consider absolute indications, identify patient trajectory, early initiation may reduce mortality.. More data needed in Cirrhosis @MaiwallRakhi
1
0
0
@doc_zubin @ajay_duseja @INASL_Liver @IsgSecretariat @drsuniltaneja @JCEH_Hepatology @AnandVKulkarni2 @DrAshish_Kumar Prof Eapen argues for the motion. Plex is underutilized in patients with ACLF and ALF. @DrAshish_Kumar @dr ashishgoel from @cmcvellore.
0
0
2
Manipulation of the Gut Liver Axis by @DrKaushalMadan1. Role of Pre/Pro/Synbiotics.. data not robust yet. ? Impact on MASLD. 🧩Obesity and Dysbiosis Alcohol 🍸 related dysbiosis Impact of antibiotics. Dysbiosis and 🧠. @DrAshish_Kumar @ajay_duseja @JCEH_Hepatology @isgcon2024
0
0
5
@ajay_duseja @AnandVKulkarni2 @RoyAHep @INASL_Liver TACE vs DEB TACE vs TARE.. Small Calibre DEB TACE.✨️
0
1
2
Nuances of Systemic Therapy in HCC based on current evidence. By Prof Amit Goel..@ajay_duseja @AnandVKulkarni2 @INASL_Liver @isgcon2024 @RoyAHep @RohitMehtaniDM @surmmcian2k6 @drsuniltaneja @DrAshish_Kumar @DrKaushalMadan1
0
5
7
Rifaximin is useful in the right setting.. being an antibiotic, principles of stewardship apply..@AnandVKulkarni2 @ebtapper @RoyAHep @nipunverma @RohitMehtaniDM @DrAshish_Kumar @JasmohanBajaj #livertwitter
0
7
19
RT @DeepikaDevuniMD: Our article is now available in the Journal of Clinical and Experimental Hepatology.. Statin Therapy is Associated Wi…
0
8
0
RT @loeymak: Thank you @apage__official for selecting us to receive the prestigious APAGE Research Programme Award ❤️ @DrHuangDQ @AnandVKul…
0
5
0
RT @TerryYip12: Appreciate the opportunity to highlight some advancements in liver cancer therapy in 2024, and obstacles hindering liver ca…
0
11
0